-
2
-
-
79952040779
-
Liver cancer epidemic in China: Past, present and future
-
Elsevier
-
Chen JG, Zhang SW (2011) Liver cancer epidemic in China: past, present and future. In: Seminars in cancer biology. Elsevier, 59-69.
-
(2011)
Seminars in Cancer Biology
, pp. 59-69
-
-
Chen, J.G.1
Zhang, S.W.2
-
3
-
-
70349272348
-
Hepatocellular carcinoma: Management of an increasingly common problem
-
Davis GL, Dempster J, Meler JD, et al. Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent). 2008;21:266-280.
-
(2008)
Proc (Bayl Univ Med Cent)
, vol.21
, pp. 266-280
-
-
Davis, G.L.1
Dempster, J.2
Meler, J.D.3
-
5
-
-
38949145743
-
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease
-
Zinkin NT, Grall F, Bhaskar K, et al. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res. 2008;14:470-477.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 470-477
-
-
Zinkin, N.T.1
Grall, F.2
Bhaskar, K.3
-
6
-
-
21744461289
-
Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma
-
Fukuda S, Itamoto T, Nakahara H, et al. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology. 2005;52:1163-1167.
-
(2005)
Hepatogastroenterology
, vol.52
, pp. 1163-1167
-
-
Fukuda, S.1
Itamoto, T.2
Nakahara, H.3
-
7
-
-
0033960899
-
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
-
Yuen MF, Cheng CC, Lauder IJ, et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000;31:330-335.
-
(2000)
Hepatology
, vol.31
, pp. 330-335
-
-
Yuen, M.F.1
Cheng, C.C.2
Lauder, I.J.3
-
8
-
-
84855338579
-
Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: Toward improved treatment decisions
-
Murakami T, Imai Y, Okada M, et al. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions. Oncology. 2011;81:86-99.
-
(2011)
Oncology
, vol.81
, pp. 86-99
-
-
Murakami, T.1
Imai, Y.2
Okada, M.3
-
9
-
-
0035128185
-
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis
-
Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48:251-259.
-
(2001)
Gut
, vol.48
, pp. 251-259
-
-
Bolondi, L.1
Sofia, S.2
Siringo, S.3
-
10
-
-
77952403490
-
Imaging of the liver for hepatocellular cancer
-
Outwater EK. Imaging of the liver for hepatocellular cancer. Cancer Control. 2010;17:72-82.
-
(2010)
Cancer Control
, vol.17
, pp. 72-82
-
-
Outwater, E.K.1
-
11
-
-
78751702512
-
CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis
-
Yu NC, Chaudhari V, Raman SS, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:161-167.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 161-167
-
-
Yu, N.C.1
Chaudhari, V.2
Raman, S.S.3
-
13
-
-
0032967477
-
The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma
-
Tu DG, Wang ST, Chang TT, et al. The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma. Cancer. 1999;85:1039-1043.
-
(1999)
Cancer
, vol.85
, pp. 1039-1043
-
-
Tu, D.G.1
Wang, S.T.2
Chang, T.T.3
-
14
-
-
34447260276
-
Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: A comparison of AFP, DCP, and AFP-L3
-
Volk ML, Hernandez JC, Su GL, et al. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark. 2007;3:79-87.
-
(2007)
Cancer Biomark
, vol.3
, pp. 79-87
-
-
Volk, M.L.1
Hernandez, J.C.2
Su, G.L.3
-
15
-
-
38349169664
-
Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?
-
Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102-114.
-
(2008)
Nat Rev Genet
, vol.9
, pp. 102-114
-
-
Filipowicz, W.1
Bhattacharyya, S.N.2
Sonenberg, N.3
-
16
-
-
33750370444
-
MicroRNA signatures in human cancers
-
Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-866.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 857-866
-
-
Calin, G.A.1
Croce, C.M.2
-
17
-
-
79651469908
-
Role of MIR-10b in breast cancer metastasis
-
Ma L. Role of miR-10b in breast cancer metastasis. Breast Cancer Res. 2010;12:210.
-
(2010)
Breast Cancer Res
, vol.12
, pp. 210
-
-
Ma, L.1
-
18
-
-
84859324831
-
MIR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer
-
Liu Z, Zhu J, Cao H, et al. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol. 2012;40:1553-1560.
-
(2012)
Int J Oncol
, vol.40
, pp. 1553-1560
-
-
Liu, Z.1
Zhu, J.2
Cao, H.3
-
20
-
-
84884967203
-
MicroRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions
-
Ouyang H, Gore J, Deitz S, et al. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions. Oncogene. 2014;33:4664-4674.
-
(2014)
Oncogene
, vol.33
, pp. 4664-4674
-
-
Ouyang, H.1
Gore, J.2
Deitz, S.3
-
21
-
-
77950370671
-
Circulating microRNAs in plasma of patients with gastric cancers
-
Tsujiura M, Ichikawa D, Komatsu S, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010;102:1174-1179.
-
(2010)
Br J Cancer
, vol.102
, pp. 1174-1179
-
-
Tsujiura, M.1
Ichikawa, D.2
Komatsu, S.3
-
22
-
-
84908066134
-
High-resolution melting analysis reveals genetic polymorphisms in MicroRNAs confer hepatocellular carcinoma risk in Chinese patients
-
Qi JH, Wang J, Chen J, et al. High-resolution melting analysis reveals genetic polymorphisms in MicroRNAs confer hepatocellular carcinoma risk in Chinese patients. BMC Cancer. 2014;14:643.
-
(2014)
BMC Cancer
, vol.14
, pp. 643
-
-
Qi, J.H.1
Wang, J.2
Chen, J.3
-
23
-
-
84884227396
-
MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells
-
Xu Y, Wang K, Gao W, et al. MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells. FEBS Lett. 2013;587:3166-3174.
-
(2013)
FEBS Lett
, vol.587
, pp. 3166-3174
-
-
Xu, Y.1
Wang, K.2
Gao, W.3
-
24
-
-
84868136612
-
MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6
-
Zhang X, Nie Y, Du Y, et al. MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. Tumour Biol. 2012;33:1589-1597.
-
(2012)
Tumour Biol
, vol.33
, pp. 1589-1597
-
-
Zhang, X.1
Nie, Y.2
Du, Y.3
-
25
-
-
84891883182
-
MicroRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition
-
Parikh A, Lee C, Peronne J, et al. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat Commun. 2014;5:2977.
-
(2014)
Nat Commun
, vol.5
, pp. 2977
-
-
Parikh, A.1
Lee, C.2
Peronne, J.3
-
26
-
-
84871610494
-
Serum MIR-18a: A potential marker for hepatitis B virus-related hepatocellular carcinoma screening
-
Li L, Guo Z, Wang J, et al. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci. 2012;57:2910-2916.
-
(2012)
Dig Dis Sci
, vol.57
, pp. 2910-2916
-
-
Li, L.1
Guo, Z.2
Wang, J.3
-
27
-
-
78649972032
-
Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma
-
Li LM, Hu ZB, Zhou ZX, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 2010;70:9798-9807.
-
(2010)
Cancer Res
, vol.70
, pp. 9798-9807
-
-
Li, L.M.1
Hu, Z.B.2
Zhou, Z.X.3
-
28
-
-
84908126667
-
Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival
-
Li T, Yin J, Yuan L, et al. Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival. Oncol Rep. 2014;31:1699-1706.
-
(2014)
Oncol Rep
, vol.31
, pp. 1699-1706
-
-
Li, T.1
Yin, J.2
Yuan, L.3
-
29
-
-
84878557630
-
Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
-
Luo J, Chen M, Huang H, et al. Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma. Onco Targets Ther. 2013;6:577-583.
-
(2013)
Onco Targets Ther
, vol.6
, pp. 577-583
-
-
Luo, J.1
Chen, M.2
Huang, H.3
-
30
-
-
84905893254
-
Diagnostic and prognostic significance of serum MIR-24-3p in HBV-related hepatocellular carcinoma
-
Meng FL, Wang W, Jia WD. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma. Med Oncol. 2014;31:177.
-
(2014)
Med Oncol
, vol.31
, pp. 177
-
-
Meng, F.L.1
Wang, W.2
Jia, W.D.3
-
31
-
-
82955217238
-
Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection
-
Qi P, Cheng SQ, Wang H, et al. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One. 2011;6:e28486.
-
(2011)
PLoS One
, vol.6
, pp. e28486
-
-
Qi, P.1
Cheng, S.Q.2
Wang, H.3
-
32
-
-
79952813995
-
Circulating microRNAs as biomarkers for hepatocellular carcinoma
-
Qu KZ, Zhang K, Li H, et al. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol. 2011;45:355-360.
-
(2011)
J Clin Gastroenterol
, vol.45
, pp. 355-360
-
-
Qu, K.Z.1
Zhang, K.2
Li, H.3
-
33
-
-
84890018024
-
Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MIR-483-5p as a potential biomarker
-
Shen J, Wang A, Wang Q, et al. Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. Cancer Epidemiol Biomarkers Prev. 2013;22:2364-2373.
-
(2013)
Cancer Epidemiol Biomarkers Prev
, vol.22
, pp. 2364-2373
-
-
Shen, J.1
Wang, A.2
Wang, Q.3
-
34
-
-
84907189442
-
A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus
-
Tan Y, Ge G, Pan T, et al. A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus. PLoS One. 2014;9:e107986.
-
(2014)
PLoS One
, vol.9
, pp. e107986
-
-
Tan, Y.1
Ge, G.2
Pan, T.3
-
35
-
-
80055117557
-
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
-
Tomimaru Y, Eguchi H, Nagano H, et al. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol. 2012;56:167-175.
-
(2012)
J Hepatol
, vol.56
, pp. 167-175
-
-
Tomimaru, Y.1
Eguchi, H.2
Nagano, H.3
-
36
-
-
84906826817
-
Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
-
Xie Y, Yao Q, Butt AM, et al. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Cancer Biol Ther. 2014;15:1248-1255.
-
(2014)
Cancer Biol Ther
, vol.15
, pp. 1248-1255
-
-
Xie, Y.1
Yao, Q.2
Butt, A.M.3
-
37
-
-
78651417662
-
Circulating microRNAs, MIR-21, MIR-122, and MIR-223, in patients with hepatocellular carcinoma or chronic hepatitis
-
Xu J, Wu C, Che X, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog. 2011;50:136-142.
-
(2011)
Mol Carcinog
, vol.50
, pp. 136-142
-
-
Xu, J.1
Wu, C.2
Che, X.3
-
38
-
-
84903413144
-
Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
-
Zhang ZQ, Meng H, Wang N, et al. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma. Diagn Pathol. 2014;9:135.
-
(2014)
Diagn Pathol
, vol.9
, pp. 135
-
-
Zhang, Z.Q.1
Meng, H.2
Wang, N.3
-
39
-
-
84555202717
-
Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma
-
Zhou J, Yu L, Gao X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol. 2011;29:4781-4788.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4781-4788
-
-
Zhou, J.1
Yu, L.2
Gao, X.3
-
40
-
-
77953585000
-
MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma
-
Liu C, Yu J, Yu S, et al. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol. 2010;53:98-107.
-
(2010)
J Hepatol
, vol.53
, pp. 98-107
-
-
Liu, C.1
Yu, J.2
Yu, S.3
-
41
-
-
68949184660
-
Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression
-
Zhang X, Liu S, Hu T, et al. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 2009;50:490-499.
-
(2009)
Hepatology
, vol.50
, pp. 490-499
-
-
Zhang, X.1
Liu, S.2
Hu, T.3
-
42
-
-
59149098054
-
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity
-
Su H, Yang JR, Xu T, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009;69:1135-1142.
-
(2009)
Cancer Res
, vol.69
, pp. 1135-1142
-
-
Su, H.1
Yang, J.R.2
Xu, T.3
-
43
-
-
35148886434
-
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
-
Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682-688.
-
(2007)
Nature
, vol.449
, pp. 682-688
-
-
Ma, L.1
Teruya-Feldstein, J.2
Weinberg, R.A.3
-
44
-
-
84867397137
-
MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells
-
Nishida N, Yamashita S, Mimori K, et al. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Ann Surg Oncol. 2012;19:3065-3071.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 3065-3071
-
-
Nishida, N.1
Yamashita, S.2
Mimori, K.3
-
45
-
-
77950877531
-
MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines
-
Tian Y, Luo A, Cai Y, et al. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem. 2010;285:7986-7994.
-
(2010)
J Biol Chem
, vol.285
, pp. 7986-7994
-
-
Tian, Y.1
Luo, A.2
Cai, Y.3
-
46
-
-
80054930119
-
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis
-
Nakata K, Ohuchida K, Mizumoto K, et al. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery. 2011;150:916-922.
-
(2011)
Surgery
, vol.150
, pp. 916-922
-
-
Nakata, K.1
Ohuchida, K.2
Mizumoto, K.3
-
47
-
-
84880347887
-
Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5
-
Yao YL, Wu XY, Wu JH, et al. Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5. Asian Pac J Cancer Prev. 2013;14:2839-2843.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 2839-2843
-
-
Yao, Y.L.1
Wu, X.Y.2
Wu, J.H.3
-
48
-
-
79151484006
-
MIR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
-
Shin KH, Bae SD, Hong HS, et al. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem Biophys Res Commun. 2011;404:896-902.
-
(2011)
Biochem Biophys Res Commun
, vol.404
, pp. 896-902
-
-
Shin, K.H.1
Bae, S.D.2
Hong, H.S.3
|